Free Trial

Blend Labs' (BLND) "Buy" Rating Reaffirmed at Canaccord Genuity Group

Blend Labs logo with Computer and Technology background

Key Points

  • Canaccord Genuity Group has reaffirmed a buy rating for Blend Labs (NYSE:BLND), setting a target price of $5.25, indicating a potential upside of 51.08% from its previous close.
  • Despite the positive outlook from Canaccord, other analysts have varied opinions, with Goldman Sachs reducing its target from $5.60 to $4.80 and UBS Group lowering from $4.00 to $3.50, reflecting a mix of ratings including "strong buy," "buy," and "hold."
  • Insider trading activity shows significant sales, with Nima Ghamsari selling 311,886 shares for approximately $904,469, leading to a 5.14% decrease in his position.
  • Interested in Blend Labs? Here are five stocks we like better.

Blend Labs (NYSE:BLND - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at Canaccord Genuity Group in a research note issued on Friday,Benzinga reports. They currently have a $5.25 price objective on the stock. Canaccord Genuity Group's price target indicates a potential upside of 46.04% from the stock's current price.

Several other equities analysts have also weighed in on BLND. JMP Securities reissued a "market outperform" rating and issued a $7.00 price objective on shares of Blend Labs in a research report on Wednesday, May 28th. Wall Street Zen upgraded shares of Blend Labs from a "sell" rating to a "hold" rating in a research report on Sunday, August 17th. The Goldman Sachs Group decreased their price target on shares of Blend Labs from $5.60 to $4.80 and set a "buy" rating for the company in a research note on Monday, May 12th. Keefe, Bruyette & Woods dropped their price target on Blend Labs from $4.00 to $3.75 and set a "market perform" rating on the stock in a report on Friday, August 8th. Finally, UBS Group cut their price objective on shares of Blend Labs from $4.00 to $3.50 and set a "neutral" rating for the company in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $4.88.

View Our Latest Analysis on BLND

Blend Labs Trading Up 3.6%

NYSE BLND traded up $0.13 during trading hours on Friday, reaching $3.60. The company's stock had a trading volume of 1,331,786 shares, compared to its average volume of 2,891,184. The business has a 50-day simple moving average of $3.36 and a 200 day simple moving average of $3.42. The stock has a market cap of $933.48 million, a PE ratio of -23.97 and a beta of 1.24. Blend Labs has a 52 week low of $2.63 and a 52 week high of $5.53.

Blend Labs (NYSE:BLND - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.05). The firm had revenue of $31.52 million for the quarter, compared to analyst estimates of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. As a group, equities analysts predict that Blend Labs will post -0.19 EPS for the current year.

Insider Buying and Selling at Blend Labs

In other news, insider Brian Kneafsey sold 25,000 shares of the stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $2.87, for a total transaction of $71,750.00. Following the completion of the transaction, the insider directly owned 696,598 shares in the company, valued at approximately $1,999,236.26. This represents a 3.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nima Ghamsari sold 311,886 shares of the firm's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $2.90, for a total value of $904,469.40. Following the transaction, the insider owned 5,754,051 shares in the company, valued at $16,686,747.90. The trade was a 5.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 561,736 shares of company stock worth $1,739,383. Corporate insiders own 35.52% of the company's stock.

Institutional Investors Weigh In On Blend Labs

A number of hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System lifted its position in shares of Blend Labs by 1.6% in the 4th quarter. California State Teachers Retirement System now owns 189,417 shares of the company's stock worth $797,000 after buying an additional 3,049 shares during the last quarter. Arizona State Retirement System raised its position in shares of Blend Labs by 6.1% during the 1st quarter. Arizona State Retirement System now owns 61,485 shares of the company's stock valued at $206,000 after acquiring an additional 3,559 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Blend Labs by 0.5% in the 1st quarter. Deutsche Bank AG now owns 1,209,057 shares of the company's stock valued at $4,050,000 after purchasing an additional 5,546 shares during the period. Quadrant Private Wealth Management LLC lifted its stake in Blend Labs by 7.8% in the first quarter. Quadrant Private Wealth Management LLC now owns 81,801 shares of the company's stock valued at $274,000 after acquiring an additional 5,892 shares during the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in Blend Labs by 18.4% during the 1st quarter. Mackenzie Financial Corp now owns 41,511 shares of the company's stock worth $139,000 after purchasing an additional 6,444 shares during the last quarter. Institutional investors and hedge funds own 52.56% of the company's stock.

Blend Labs Company Profile

(Get Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

Further Reading

Analyst Recommendations for Blend Labs (NYSE:BLND)

Should You Invest $1,000 in Blend Labs Right Now?

Before you consider Blend Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.

While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.